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Abstract
Background: Sensory abnormalities are a key feature of Complex Regional Pain Syndrome (CRPS). In order to characterise
these changes in patients suffering from acute or chronic CRPS I, we used Quantitative Sensory Testing (QST) in comparison
to an age and gender matched control group.
Methods: 61 patients presenting with CRPS I of the upper extremity and 56 healthy subjects were prospectively assessed
using QST. The patients’ warm and cold detection thresholds (WDT; CDT), the heat and cold pain thresholds (HPT; CPT) and
the occurrence of paradoxical heat sensation (PHS) were observed.
Results: In acute CRPS I, patients showed warm and cold hyperalgesia, indicated by significant changes in HPT and CPT.
WDT and CDT were significantly increased as well, indicating warm and cold hypoaesthesia. In chronic CRPS, thermal
hyperalgesia declined, but CDT as well as WDT further deteriorated. Solely patients with acute CRPS displayed PHS. To a
minor degree, all QST changes were also present on the contralateral limb.
Conclusions: We propose three pathomechanisms of CRPS I, which follow a distinct time course: Thermal hyperalgesia,
observed in acute CRPS, indicates an ongoing aseptic peripheral inflammation. Thermal hypoaesthesia, as detected in acute
and chronic CRPS, signals a degeneration of A-delta and C-fibres, which further deteriorates in chronic CRPS. PHS in acute
CRPS I indicates that both inflammation and degeneration are present, whilst in chronic CRPS I, the pathomechanism of
degeneration dominates, signalled by the absence of PHS. The contralateral changes observed strongly suggest the
involvement of the central nervous system.
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Introduction
Complex Regional Pain Syndrome (CRPS) is a neuropathic
pain disorder, evolving after limb trauma either without (CRPS I),
or with definable nerve lesion (CRPS II) [1]. Beyond pain,
autonomic, trophic and motor disturbances, sensory abnormalities
are key symptoms of CRPS [2], typically not confined to the
innervation territory of peripheral nerves or nerve roots.
Conspicuously, CRPS sensory abnormalities may spread in a
hemisensory manner [3] or even contralaterally [4]. No generally
accepted animal model of CRPS I exists, but very recently an
ischemia-reperfusion injury model reproduced some changes
observed in humans [5] (but see [6]).
A sequence of disease symptoms has been described [7,8],
characterized by initial signs of regional inflammation (edema and
sudomotor disturbances), followed by functional atrophy. Others
identified three distinct subtypes, but debated a chronological
succession [9].
Several hypotheses about the pathophysiology of CRPS have
been proposed emphasizing the importance of peripheral
neurogenic inflammation [10,11], small-fibre axonal degeneration
[12,13] or central changes (cortical reorganisation) [14–16] similar
to other pain disorders [17], since cortical changes were related to
measures of pain plasticity (hyperalgesia) rather than spontaneous
pain [14,15]. Others suggested an interaction of peripheral and
central nervous changes [18].
Although sensory alterations accompanying CRPS can be
assessed by quantitative sensory testing (QST) [19], little is known
about the distinct patterns of these changes, nor their possible time
course. A standardised controlled prospective analysis of the sensory
changes in acute and chronic stages of CRPS I might provide novel
insights into the pathophysiology of the disease. Moreover, since the
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majority of sensory data rely on side-to-side comparison [3,19], a
rigorous investigation into the possible presence and magnitude of
contralateral symptoms is of major importance.
Therefore, we conducted a prospective study, investigating an
unbiased sample of patients suffering from acute or chronic CRPS
I of the upper extremity as well as an age- and gender-matched
healthy control group. Patients with CRPS II or CRPS of the
lower extremities were excluded, since the probable pathophysi-
ology of CRPS I differs from CRPS II, and sensory thresholds of
upper and lower extremities differ significantly [20]. The goal of
the study was to delineate differences in the ipsi- and contralateral
sensory profiles in acute and chronic CRPS I.
Material and Methods
Patients and Control Subjects
Over a period of nine months, 61 consecutive patients
presenting with the diagnosis CRPS I of the upper extremity (7
male, 54 female, mean age 59.1612.9 years) agreed to participate
in the study. The diagnosis CRPS I was established by experienced
examiners according to the research diagnosis criteria proposed by
Bruehl [2] (Table 1) as well as the IASP criteria for CRPS [1].
Duration of CRPS was defined as the time since the inciting event,
as the beginning of CRPS symptoms could not always be clearly
defined. Patients assigned into two groups related to duration of
disease: patients with CRPS for twelve months or less were
considered as ‘‘acute CRPS’’ (n = 27), while patients with a longer
history (.12 months, n = 34) were considered as ‘‘chronic CRPS’’
(Figure 1). This cut-off point was chosen in accordance with the
stages as described by Bonica [8]. 56 healthy subjects, matched for
gender and age (16 males, 40 females, mean age 56.8612.3 years)
were examined in the same way as the CRPS patients.
Demographic data of patients and control subjects are shown in
table 2. All patients and subjects presenting with diseases other
than CRPS, which potentially affect sensory testing, i.e. diabetes,
polyneuropathy, as well as individuals with mental disease were
excluded from the study. Also, patients with hearing or speech
disorders, as well as patients with other communication problems
were excluded. The study was approved by the local ethics
committee, and written informed consent was obtained by all
subjects enrolled in the study according to the Declaration of
Helsinki.
Figure 1. Duration of disease in patients with acute and chronic CRPS. No intersection between both groups occurred.
doi:10.1371/journal.pone.0002742.g001
Table 1. Proposed modified research diagnostic criteria for CRPS. *
1: Continuing pain which is disproportionate to any inciting event
2: Must report at least one symptom in each of the four following
categories 3: Must display at least one sign in two or more of the following categories
Sensory: reports of hyperesthesia Sensory: evidence of hyperalgesia (to pinprick) and/or allodynia (to light touch)
Vasomotor: reports of temperature asymmetry and/or skin color changes
and/or skin color asymmetry
Vasomotor: evidence of temperature asymmetry and/or skin color changes and /or
asymmetry
Sudomotor/edema: reports of edema and/or sweating changes and/or
sweating asymmetry
Sudomotor/edema: evidence of edema and/or sweating changes and/or sweating
asymmetry
Motor/trophic: reports of decreased range of motion and/or motor
dysfunction (weakness, tremor, dystonia) and or throphic
changes (hair, nail, skin)
Motor/trophic: evidence of decreased range of motion and/or motor dysfunction
(weakness, tremor, dystonia, and/or trophy changes (hair, nail, skin)
*Bruehl S, Harden RN, Galer BS et al. External validation of IASP diagnostic criteria for Complex Regional Pain Syndrome and proposed research diagnostic criteria.
International Association for the Study of Pain. Pain 1999; 81: 147–154.
doi:10.1371/journal.pone.0002742.t001
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Testing Conditions
All tests were performed under minimal distraction in a silent,
air-conditioned room, with an ambient temperature of 25–
26uCelsius. Subjects were seated on a comfortable chair, and
allowed to adapt to the test environment for at least 20 minutes.
QST followed a standardised protocol as described by Rolke and
colleagues [21], but solely the thermal testing part of this protocol
was performed. The course of assessments was explained to the
subjects by written standard patient instructions. All sensory tests
were demonstrated in a remote test area (forearm) not affected by
the underlying disease.
Equipment
Thermal testing was performed using a Medoc Thermal
Stimulus Analyser TSA-2001 device (Medoc, Ramat Yishai,
Israel) using a computer-controlled Peltier-based probe. The basic
principles of the Peltier stimulator are described in detail elsewhere
[22]. The 30630 mm Peltier element was attached to the patients’
hand dorsum by means of an elastic tape. The probe was placed in
a way that an optimal contact between the hand and the probe
was achieved. The hand affected by the disease was termed
‘‘ipsilateral’’, while the other hand was termed ‘‘contralateral’’.
Thermal testing commenced in the contralateral side. In healthy
control subjects, the dominant hand was termed ‘‘ipsilateral’’.
Test Algorithm
Warm detection threshold (WDT), cold detection threshold
(CDT), thermal sensory limen (TSL), cold pain threshold (CPT),
and heat pain threshold (HPT) were measured using the method of
limits as follows: For determination of WDT, CDT, CPT and
HPT, subjects were applied three successive stimulations starting
from a baseline temperature of 32uC. The rate of temperature
increase or decrease respectively was 1uC/s. For WDT and CDT,
subjects were instructed to press the response button as soon as
sensation of cold or warm was detected. For detection of CPT and
HPT the patients pressed the button to indicate the onset of cold
pain or heat pain. After the button was pressed, the temperature
returned immediately to baseline. For safety reasons, the minimal
and maximal temperatures allowed were 0uC and 50uC to avoid
tissue damage. If the individual pain threshold was not reached
within these confines, 0uC or 50uC were assigned as surrogate pain
threshold measures. A computer-generated random interval
ranging from five to fifteen seconds was intercalated between
stimulations. TSL was estimated as the difference limen for cold
and warm thresholds when cold and warm stimuli were given in
alternating order. For this reason, six alternating warm and cold
stimuli were applied without returning to the baseline tempera-
ture. Patients were instructed to press the test button when a warm
or cold sensation was felt. Subjects were also asked to identify the
quality of the sensation at any time a cold or warm stimulus was
given. Identification of a cold stimulus as either hot or burning
pain was denoted as the occurrence of paradoxical heat sensation
(PHS) [23]. For additional details see Rolke and colleagues [21].
The standard order of tests for all patients was: CDT, WDT, TSL,
CPT, and HPT. Total duration of sensory testing was about
45 minutes.
Clinical Presentation
In patients presenting with CRPS, clinical data were assessed
with a standardised protocol obtaining data on the magnitude of
pain, edema, skin temperature and levels of depression. Pain
ratings were assessed by means of a numeric rating scale (NRS)
from 0 to 10. Patients reported the pain level in the ipsilateral
hand at the time of presentation. Furthermore, the presence or
absence of edema was evaluated by the examiner in a
dichotomous way (yes/no). Skin temperature was measured in
three consecutive tests on the dorsum of each hand, applying
infrared thermometry (PROSCAN 510, TFA Dostmann, Reich-
olzheim, Germany). Symptoms of depression were assessed by
means of the German version of the Center for Epidemiological Studies
Depression Test (CES-D). This test combines twenty questions
designed to measure levels of depression [24,25]. A raw test score
of 27 or more is considered to be the critical limit for the presence
of a depressive episode in pain patients [26].
Data Analysis
Demographic and clinical data were compared using an
unpaired t-test. Gender proportions as well as the presence of
edema were tested by Yates-corrected chi-square. Kolmogorov-
Smirnov’s test was performed to assess deviations from normal
distribution in demographic data.
For analysis of WDT and CDT, the mean of the three
measurements of temperature change from the baseline temper-
ature of 32uC was calculated. Likewise, TSL was calculated as the
Table 2. Characteristics of CRPS patients and control subjects.
Control
(n =56)
All CRPS
(n =61)
Acute CRPS
(n=27)
Chronic CRPS
(n =34)
P-value CRPS
vs. Controls
P-value Acute
vs. Chronic CRPS
Age (years) Mean6SD 56.8612.3 59.1612.9 56.0612.8 61.6612.5 0.327 * 0.092 *
Gender (female/male) 40 / 14 54 / 7 25 / 2 29 / 5 0.078 # 0.628 #
Time since inciting event
(months) Mean6SD
22.4620.4 3.562.1 37.4615.1 ,0.0001 *
Pain rating (NRS) Mean6SD 2.4862.62 (n = 60) 2.7762.55 (n = 26) 2.2662.69 0.853*
Presence of Edema (%) 31 / 59 (52.5% 24 / 25 (96.0%) 7 / 34 (20.6 %) ,0.0001#
Difference in skin temperature
(Ipsi- vs. contralateral hand)
Mean6SD
20.0360.89 (n = 58) +0.2561.00 (n = 24) 20.2260.78 ,0.05*
Depression Score (CES-D)
Mean6SD
18.7610.2 (n = 45) 19.569.5 (n = 21) 18610.9 (n = 24) 0.612*
*unpaired t-test
#Yates-corrected chi-square
doi:10.1371/journal.pone.0002742.t002
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mean difference between cold and warm thresholds at alternating
stimulation. CDT, WDT and TSL data were transformed into
decadic logarithms to achieve secondary normal distributions of
these data. For CPT and HPT the arithmetic means were used for
analysis. Data were analysed by two way analysis of covariance
(ANCOVA) with the main factors: group (controls, acute and
chronic CRPS) and body side (ipsilateral vs. contralateral), and the
covariate age in order to control for the known age-dependency of
somatosensation [20]. The locus of significance was identified by
post hoc least significant differences (LSD) tests.
Data were also normalized relative to the mean and standard
deviation (SD) of the control group (z-transformation) according to
the formula: z = (x2meancontrol)/SDcontrol. This operation ren-
dered all z-transformed data directly comparable in units of SD of
the control group. Z-transformed data were analysed by four way
analysis of covariance (ANCOVA) with the main factors: group
(controls, acute and chronic CRPS), body side (ipsilateral vs.
contralateral), sensory dimension (nociceptive vs. non-nociceptive),
and thermal modality (hot vs. cold) and the covariate age.
The impact of the presence or absence of PHS was also
analyzed by two way analysis of covariance (ANCOVA) with the
main factors: PHS (PHS+ vs. PHS2) and body side (ipsilateral vs.
contralateral), and the covariate age. In addition, all parameters
were entered into a forward stepwise multiple regression equation,
in order to identify which parameters significantly predicted the
occurrence of PHS. A probability level of p,0.05 was considered
significant, p,0.10 was considered a significant trend. All analysis
was performed using the STATISTICAH software package
(STATISTICAH 4.5, Statsoft, Tulsa, USA).
Results
Patients and Control Subjects
There was no difference in mean age between CRPS I patients
and healthy subjects, both groups exhibited normal distributions of
age. CRPS duration, however, exhibited an obvious bimodal
distribution (Figure 1, Table 2).
No differences were found concerning the levels of pain as well
as depression between acute and chronic CRPS patients (Table 2).
However, almost all patients in the acute CRPS group displayed
clinical signs of edema (24/25 patients = 96%), which were only
present in a minority of chronic CRPS patients (7/34 pa-
tients = 20.6%, p,0.0001; Table 2). Overall, there was no
difference in skin temperature between both hands. However, in
the acute CRPS group, the ipsilateral hand was warmer when
compared to the contralateral hand (D= +0.2561.00uC), whilst in
the chronic CRPS group, the ipsilateral hand was colder
(D=20.2260.78uC). When comparing both groups, this differ-
ence reached statistical significance (p,0.05).
Thermal Detection Thresholds
ANCOVA with age as a covariate (partialing out the highly
significant age-related effects) revealed a highly significant effect of
group (F2,113 = 30.04, p,,0.0001), body side (ipsilateral vs.
contralateral: F1,113 = 12.39, p,0.001) and group x side interac-
tion (F2,113 = 4.65, p,0.05) for the cold detection threshold
(CDT). In healthy control subjects, CDT was highly correlated
(r = 0.74, p,0.0001) and very symmetrical between body sides
(mean CDT: 1.27 vs. 1.26uC; p= 0.88) (Table 3). In contrast,
CDT was significantly less correlated between body sides in CRPS
patients (r = 0.43, p,0.001; difference of correlation vs. controls:
p,0.02). CDT was significantly increased in acute CRPS patients
(2.25uC; p,,0.0001 vs. controls) and even more increased in
chronic CRPS (3.66uC; p,,0.0001 vs. controls and p,0.001 vs.
acute CRPS) (Figure 2A). CDT in the contralateral hand of acute
CRPS patients was significantly lower than in the ipsilateral hand,
and although marginally increased (1.45uC), it did not differ from
healthy controls (p = 0.26). In contrast, in chronic CRPS, CDT
was considerably increased in the contralateral hand with only a
marginal difference to the ipsilateral hand (2.85uC, p,,0.0001
vs. controls and acute CRPS; p,0.05 vs. affected hand)
(Figure 2A). Thus, patients with acute CRPS displayed pro-
nounced ipsilateral cold hypoaesthesia. In chronic CRPS, this
phenomenon was more pronounced and also found in the
contralateral hand.
Warm detection thresholds (WDT) exhibited a similar overall
pattern: ANCOVA (group: F2,113 = 27.66, p,,0.0001, body side:
F1,113 = 13.12, p,0.001, and group x side interaction:
F2,113 = 4.22, p,0.05), loss of symmetry (2.16uC vs. 2.19uC;
p= 0.88 in healthy controls), and deterioration of correlation
between sides (r = 0.56 vs. r = 0.35) (Table 3). WDT was increased
in the ipsilateral hand of acute and chronic CRPS patients (4.48uC
and 5.18uC; p,0.001 each vs. controls) (Figure 2B). Furthermore,
WDT was significantly increased in the contralateral hand of acute
and chronic CRPS (2.87uC and 4.16uC; p,0.01 and p,,0.0001
vs. controls) (Figure 2B). In aggregate, there was warm detection
hypoaesthesia in the ipsilateral and contralateral hands of acute or
chronic CRPS patients with no significant difference between
hands in the chronic CRPS group.
Thermal sensory limen (TSL), assessed by alternating CDT and
WDT, yielded the same results: ANCOVA (group: F2,113 = 22.42,
p,,0.0001, body side: F1,113 = 19.12, p,0.001 and group x side
interaction: F2,113 = 10.36, p,0.0001) revealed a strong ipsilateral
threshold increase in acute CRPS, even more increased in chronic
Table 3. Thermal detection in acute and chronic CRPS.
Group Acute CRPS Chronic CRPS Control
Examined Hand Ipsilateral Contralateral Ipsilateral Contralateral Dominant Contralateral
CDT Mean
(Mean log6SD)
2.25uC (0.35360.377) 1.45uC (0.16060.258) 3.66uC (0.56460.338) 2.85uC (0.45560.257) 1.27uC (0.10660.249) 1.26uC (0.10060.253)
WDT Mean
(Mean log6SD)
4.48uC (0.65160.337) 2.87uC (0.45760.263) 5.18uC (0.71460.297) 4.16uC (0.61960.247) 2.16uC (0.33460.222) 2.19uC (0.34060.226)
TSL Mean
(Mean log6SD)
7.47uC (0.87360.378) 4.59uC (0.66260.281) 9.00uC (0.95460.288) 6.49uC (0.81260.211) 3.30uC (0.51860.269) 3.56uC (0.55160.260)
Cold Detection Threshold
WDT: Warm Detection Threshold
TSL: Thermal Sensory Limen
doi:10.1371/journal.pone.0002742.t003
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CRPS (7.47uC and 9.00uC vs. 3.30uC in controls; p,,0.0001
each). A similar pattern was observed in the contralateral hand
(4.59uC and 6.49uC; p,,0.0001, each vs. controls, and p,0.005,
each vs. the affected hand) (Table 3).
Thermal Pain Thresholds
A very different pattern was found for thermal pain thresholds.
Heat pain thresholds (HPT) exhibited a highly significant group
effect in ANCOVA (F2,113 = 7.33, p,0.001), but neither body
side, nor group x side interaction were significant (both p.0.70).
HPT was symmetrical in all groups (p.0.50 each) and
significantly correlated between body sides although significantly
less well in CRPS (r = 0.52 vs. r = 0.77, p,0.05). HPT was
significantly lowered in acute CRPS patients when compared to
healthy controls (42.6560.87uC vs. 45.2460.41uC, p,0.001). In
chronic CRPS, however, HPT had almost normal values
(44.2160.74uC, p.0.10 vs. controls, but p,0.001 vs. acute
CRPS; Figure 3B, Table 4). Thus, acute CRPS patients displayed
a bilateral heat hyperalgesia, almost absent in chronic CRPS.
Likewise, cold pain thresholds (CPT) exhibited a highly
significant effect of group (F2,113 = 11.84, p,0.0001) and body
side (F1,113 = 7.75, p,0.01) in ANCOVA, but no group x side
interaction (p= 0.22). High symmetry (mean CPT: 9.8361.30 vs.
9.4561.19uC; p= 0.65) and correlation in healthy subjects was not
found in CRPS patients (r = 0.70 vs. r = 0.85) (p,0.05 vs.
controls:) (Table 4). Acute CRPS patients exhibited bilateral cold
hyperalgesia (CPT: 20.1861.64uC ipsilaterally and 17.2961.60uC
contralaterally, p,,0.0001 each vs. controls; side-to-side com-
Figure 2. Thermal detection in acute and chronic CRPS. Cold detection thresholds (A) and warm detection thresholds (B), shown as change
(DuC) from the adaption temperature of 32uC. Thresholds are significantly increased in acute and chronic CRPS. Significant increases are also found in
the contralateral ‘‘unaffected’’ hand. Significance vs. controls: ** p,0.01, *** p,0.001; Significance vs. acute CRPS: ++ p,0.01, +++ p,0.001;
Significance vs. ipsilateral hand: (1) p,0.10, 1 p,0.05, 111 p,0.001. Note: Significance marks that bridge symbols of ipsilateral and contralateral hands
apply to both hands. Error bars show 1SEM.
doi:10.1371/journal.pone.0002742.g002
Figure 3. Thermal pain thresholds in acute and chronic CRPS. Cold pain thresholds (A) and heat pain thresholds (B) are significantly lowered
in acute CRPS (corresponding to cold and heat hyperalgesia). Pain partially (cold pain) or totally (heat pain) recovers to normal in chronic CRPS.
Significant increases of similar magnitude are also found in the contralateral ‘‘unaffected’’ hand for heat pain (B) and to a lesser extent in cold pain
(A). Significance vs. controls: *** p,0.001; Significance vs. acute CRPS: +++ p,0.001; Significance vs. ipsilateral hand: (1) p,0.10, 1 p,0.05. Note:
Significance marks that bridge symbols of ipsilateral and contralateral hands apply to both hands. Error bars show 1SEM.
doi:10.1371/journal.pone.0002742.g003
QST in CRPS
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parison p,0.05). In chronic CRPS, when compared to acute
CRPS, cold hyperalgesia was significantly less pronounced tending
towards normal thresholds (15.7961.69uC in the ipsilateral and
13.8861.64uC in the contralateral hand; p,,0.0001 each vs.
acute CRPS). However, CPT remained significantly different from
controls (p,0.0001 in both hands) (Figure 3A).
A Standardised View of Thermal Sensitivity in CRPS
Patients
The pattern of changes in different parameters of thermal
sensitivity were compared in normalized data (z- transformed vs.
control subjects) [21] (Figure 4). ANCOVA on normalized QST
data correcting for the significant age-dependency of all QST
parameters (Rao’s R=8.26 for covariate age, p,,0.0001) revealed
significant main effects of group, side, thermal detection vs. thermal
pain (all p,0.001), but not of thermal modality (hot vs. cold,
p= 0.25). Notably, group x side interaction was weak and failed to
reach significance (F2,113= 2.37, p= 0.07), indicating that overall
side differences of sensitivity in CRPS patients were not marked. In
contrast, a highly significant interaction for group x thermal
detection vs. thermal pain was found (F2,113 = 46.62, p,,0.0001)
based on pronounced sensory loss (thermal hypoaesthesia) relative
to the control group in acute CRPS, and even more pronounced in
the chronic stage. In contrast, a gain (hyperalgesia) in thermal pain
(CPT, HPT) was found, which was less marked in the chronic stage
of CRPS (Figure 4). A highly significant interaction of side x thermal
detection vs. pain (F1,113 = 23.28, p,,0.0001) was based on more
prominent sensory loss in thermal detection in the affected hand of
CRPS patients. Separate ANCOVAs for thermal detection or pain
thresholds of CRPS patients confirmed a significant asymmetry of
loss in thermal detection (affected .. contralateral; F1,113= 26.28,
p,0.0001), but not in thermal pain (F1,113 = 0.22, p= 0.63).
Paradoxical Heat Sensations
Paradoxical heat sensations (PHS) occurred in only 1/336 TSL
trials in both hands of healthy controls (0.3%). In contrast, PHSwas a
very frequent finding in the affected and contralateral hand in acute
CRPS (9/20 patients and 25/60 tests =41.7% and 9/25 patients and
27/75 tests= 36%, p,,0.0001 each vs. controls; p,0.05 affected vs.
contralateral hand; Spearman R rank correlation=0.87 between
both hands; Figure 5A). In contrast, PHS was almost completely
absent in chronic CRPS and only encountered in 3/93 tests
ipsilaterally (3.2%) in 2/31 patients and 0/99 tests contralaterally (0/
33 patients; both p,,0.0001 vs. acute CRPS).
In further analyses, the impact of the presence (PHS+) or
absence (PHS2) of PHS on any other sensory measure was
Table 4. Thermal nociception in acute and chronic CRPS.
Group Acute CRPS Chronic CRPS Control
Examined Hand Ipsilateral Contralateral Ipsilateral Contralateral Dominant Contralateral
HPT Mean6SD 42.6560.87uC 42.4460.72uC 44.2160.74uC 44.5660.72uC 45.2460.41uC 45.3960.40uC
CPT Mean6SD 20.1861.64uC 17.2961.60uC 15.7961.69uC 13.8861.64uC 9.8361.30uC 9.4561.19uC
HPT: Heat Pain Thresholds
CPT: Cold Pain Threshold
doi:10.1371/journal.pone.0002742.t004
Figure 4. Standardised comparison of QST data normalised to mean and standard deviation of the control group (z-normalisation).
Normalised data show a severe sensory loss in acute CRPS for all thermal detection parameters (CDT, WDT, TSL) in the affected ipsilateral hand (.1
SD of controls), but also a moderate loss in the contralateral hand, which aggravates in chronic CRPS. In contrast, there is a substantial gain in thermal
nociception (CPT, HPT) in acute CRPS (hyperalgesia), equally expressed in both hands (<1 SD of controls). Heat hyperalgesia almost fully subsides in
chronic CRPS, while significant cold hyperalgesia is retained. For the sake of clarity there are no symbols of statistical significance in this figure (c.f.
respective paragraph in results).
doi:10.1371/journal.pone.0002742.g004
QST in CRPS
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explored. ANCOVAs (corrected for age) revealed no impact of
PHS+ or PHS2 on either CDT, WDT, TSL or HPT (all p.0.40).
In contrast, PHS+ and PHS– patients differed significantly in their
cold pain thresholds (ANCOVA: F1,42 = 7.36, p,0.01). PHS+
patients displayed significantly more cold pain hyperalgesia than
PHS– patients (mean CPT: 21.2461.55uC vs. 16.3161.73uC,
p,0.05), but no difference in e.g. heat hyperalgesia (mean HPT:
43.2860.75uC vs. 42.4461.11uC, p= 0.47; Figure 5B).
Stepwise multiple regression analysis identified three variables
that significantly predicted the occurrence of PHS (multiple
regression R=0.55, p,0.002), namely age (partial r = 0.44,
p,0.005), duration of acute CRPS (partial r = 0.35, p,0.05),
and CPT (partial r = 0.39, p,0.02).
Discussion
As there is a vivid discussion about the pathophysiological
mechanisms underlying CRPS I and II [10,12,14], there are still
only few publications providing quantitative information about the
sensory changes occurring in this neuropathic pain disorder.
Despite the fact that sensory changes are a ‘‘conditio sine qua
non’’ for the diagnosis of a CRPS [1,2], the character, degree and
chronological order of those changes are relatively unexplored,
and therefore, the pathomechanisms remain cryptic. The studies
hitherto applying Quantitative Sensory Testing (QST) for patients
with CRPS revealed inconsistent or even partially conflicting
results. Thimineur and colleagues were the first to describe sensory
changes contralateral to the affected side. However, they could not
define a distinct thermal sensory profile concerning the affected
limb [4]. The largest number of CRPS-patients characterised by a
structured QST protocol examined 57 patients, respectively. This
study demonstrated warm hypoaesthesia as well as cold hyperal-
gesia in the affected limb [19]. Eisenberg and colleagues tested a
small sample of 12 patients with CRPS of either the upper or
lower extremity and reported significant changes in heat and cold
pain thresholds, but not in the detection thresholds for warm and
cold [27]. None of these groups were able to detect changes in the
contralateral limb. Paradoxical heat sensation was not tested in
either of these studies. It may be noted, that all indexed studies
substantially differ in their applied QST protocols. Recently,
U¨c¸eyler and colleagues were the first to apply a standardised
protocol, as suggested by the German Research Network on
Neuropathic Pain (DFNS) including thermal testing, PHS and
mechanical testing [28]. In their study, 32 patients suffering from
CRPS I or II were examined by means of QST, showing
significant thermal hypoesthesia in the diseased limb.
In the study at issue, a standardised protocol for thermal testing
was used [21]. Patients suffering from CRPS I of the upper
extremity were included in the study, exclusively. No patients with
CRPS II or CRPS of the lower extremities were enclosed, as the
probable pathophysiology of CRPS I differs from CRPS II, and
the sensory thresholds of the upper extremity significantly differ
from those on the lower extremity [20]. The precise assessment of
the time since inciting event enabled to define the sensory changes
occurring at different stages of the disease. Furthermore, an age
and gender matched control group was tested, in order to reveal
differences in sensory profiles in CRPS patients compared to
healthy subjects.
Distinction Between the Acute and Chronic CRPS Group
The distinction of acute vs. chronic CRPS was justified by a
natural gap in an obviously bimodal distribution concerning
duration of disease (Figure 1). Furthermore, patients in the acute
group displayed more pronounced clinical signs of inflammation,
as signalled by the occurrence of edema and a positive side to side
difference in skin temperature (Table 2). This preponderance of
inflammatory signs in acute CRPS is in accordance with the
literature [7,29,30]. In the chronic CRPS group, a considerably
lesser occurrence of edema was registered, and concomitantly, the
overall side to side difference in skin temperature was negative.
Figure 5. (A) Paradoxical heat sensation (PHS) to mild cold stimuli as elicited by alternating cold and warm stimulation (TSL). PHS
was a frequent finding in both hands in acute CRPS, and fully subsided in the chronic phase. Significance vs. controls: *** p,0.001; Significance vs.
acute CRPS: +++ p,0.001; Significance vs. ipsilateral hand: (1) p,0.10, 1 p,0.05. Note: Significance marks that bridge symbols of ipsilateral and
contralateral hands apply to both hands. (B) PHS-positive CRPS patients (PHS+) exhibited a significantly more pronounced cold hyperalgesia than
PHS-negative CRPS patients (PHS2). In contrast, there was no such difference in heat hyperalgesia. Error bars show 1SEM.
doi:10.1371/journal.pone.0002742.g005
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Possible Pathomechanisms of Acute CRPS
Inflammation. Besides pain, acute CRPS is inter alia
accompanied by edema, reddening and increased skin
temperature. Any of these symptoms (tumor, calor, rubor)
suggest the presence of inflammation, and thus it has been
hypothesized, that at least in the early phase, aseptic inflammation
is a critical feature of CRPS [7]. As neurogenic mechanisms
strongly contribute to aseptic inflammation [31], neurogenic
inflammation might be a possible starting point of the
inflammatory process in CRPS. This is underlined by
experimental findings of increased levels of calcitonine gene-
related peptide (CGRP) and facilitated neurogenic inflammation
in acute CRPS [10,32].
In this study, the presence of heat hyperalgesia in the acute CRPS
group indicates peripheral sensitisation of heat-sensitive C-fibre
nociceptors, which is a hallmark sign of inflammatory processes
[33]. The simultaneous presence of cold hyperalgesia can also be
explained by peripheral sensitisation, as Wasner and colleagues
have shown that cold hyperalgesia in humans is likely mediated by
sensitisation of cold-sensitive C-nociceptors [34]. The existence of
hyperalgesia for noxious heat and cold stimuli in acute CRPS
strongly supports the hypothesis of an inflammatory process [35].
Small Fibre Degeneration
Apart from signs of inflammatory hyperalgesia, our findings
suggest a pronounced degeneration of thinly myelinated A-delta
cold fibres as well as unmyelinated C warm fibres in acute CRPS.
The degeneration hypothesis is based on a highly significant
increase in warm and cold detection thresholds, indicating
emerging A-delta and C-fibre dysfunction [22,36,37] (Figure 2).
This degenerative process might be triggered by the ongoing
aseptic inflammation.
Apart from inflammation, the presence of cold hyperalgesia can
also be explained by a second mechanism. This involves central
disinhibition of cold-sensitive nociceptive pathways, namely by an
degenerative insufficiency of A-fibre inputs to control nociceptive
inputs, since cold hyperalgesia is reliable induced by experimental
acute and selective A-fibre conduction blockade [34]. Wasner and
colleagues interpreted this effect as a lack of C-fibre inhibition
normally exerted by a concomitant activation of cold sensitive A-
delta fibres.
The hypothesis of cold pain hyperalgesia being caused by a
combination of inflammation and A-delta-fibre degeneration is
emphasised by the incomplete recovery of CPT in chronic CRPS.
Heat hyperalgesia, which is mainly caused by inflammatory C-
fibre sensitisation, resolved almost completely, as suggested by a
return of HPT to almost normal values in the chronic stage of the
disease. At the same time, significant cold hyperalgesia persisted in
the chronic stage, when signs of axonal degeneration were even
more pronounced (see Figure 3).
Synergism of Inflammation and Small Fibre Degeneration
in Acute CRPS
Paradoxical heat sensation (PHS), i.e. a sensation of hot or
burning pain to mild cold stimulation following a preceding mild
warm stimulus, represents a disturbance of sensory integration in
thermosensation. It is hardly ever present in the hands of healthy
subjects (never in females of any age, and only at a rate of 0.6% in
males .40 years of age) [20]. In contrast, in the study at issue, the
prevalence of PHS in acute CRPS patients was unusually high
(approximately 40%). Two mechanisms contribute to the
appearance of PHS, either disinhibition of a heat-sensitive C-fiber
pathway by blockade, or loss of A-fibre input and facilitation of
this already disinhibited pathway by sensitisation of the respective
primary afferents [23,38]. The presence of PHS fosters the
hypothesis of a synergism of inflammation and small fibre
degeneration as being the two major pathomechanisms acting in
acute CRPS. Thus, in PHS, the disturbance of sensory integration
is hypothesised to be based on A-fibre loss. This is supported by
the strong increase in cold detection threshold, suggesting an at
least partially dysfunctional cold-sensing A-delta fibre pathway,
which in turn disinhibits the cold-sensitive polymodal nociceptive
C-fibre pathway. The C-fibre pathway was boosted by inflamma-
tory sensitisation, thus further increasing the likelihood of PHS.
This is in accordance with the finding, that cold hyperalgesia was
partially resolved in chronic CRPS, but remained significantly
present at a lesser level, although the inflammatory hyperalgesia
was fully resolved, as signified by the absence of heat hyperalgesia.
Notably, PHS did not occur anymore in chronic CRPS (see
Figure 5A). The positive correlation between cold pain hyperal-
gesia and the occurrence of PHS in acute CRPS additionally
confirms the hypothesis, that cold pain hyperalgesia, just like PHS,
is caused by A-delta fibre degeneration as well as inflammation
(Figure 5B). Moreover, the correlation between CPT and HPT
leads to the suggestion, that inflammatory hyperalgesia (indicated
by the lowering of HPT) also had an impact on cold pain
sensitivity and hence indirectly on the presence of PHS.
Possible Pathomechanisms of Chronic CRPS
Progressing Small Fibre Degeneration. In chronic CRPS,
symptoms of inflammation disappear, while neurological signs of
small nerve fibre degeneration prevail. As discussed above,
paradoxical heat sensation not only requires an A-delta fibre
dysfunction, but is also more likely to occur when C-fibre input is
increased, as in the condition of inflammatory peripheral
sensitisation. In chronic CRPS, when clinical signs of
inflammation subside, PHS was thus almost absent.
Furthermore, no heat hyperalgesia was detectable, indicating the
absence of a relevant peripheral inflammation. Additionally, cold
as well as warm detection thresholds deteriorated, indicating a
further impairment of small fibre function. This is in order with a
recent study by Oaklander and colleagues, showing that CRPS I
leads to small fibre axonal degeneration [12]. Interestingly, of the
18 patients participating in their study, only two had a history of
disease shorter than one year, so most of their patients met our
criteria for chronic CRPS.
Contralateral Sensory Changes
Unexpectedly, in acute as well as in chronic CRPS I, QST-
results revealed changes in the contralateral hand, which mirrored
the sensory changes in the hand primarily affected by the disease.
These changes were not always as pronounced as the alterations
on the ipsilateral (affected) side. Namely, there was a lesser degree
of loss of cold and warm detection. Notably however, hyperalgesia
in acute CRPS was equally pronounced on the ipsilateral as well as
on the contralateral side. This might necessitate the conclusion,
that inflammatory hyperalgesia is not limited to the affected limb.
This may be related to an exaggerated level of neurogenic
inflammation, since an increased axon reflex vasodilation has been
shown to occur in the contralateral hand of former CRPS patients
[39]. We suggest that neurogenic inflammation might be a
predisposing factor for the development of this disease. A bilateral
interaction has been demonstrated for neurogenic inflammation,
which is accompanied by a segmentally organised short-lived
suppression of this inflammatory response in the innervation
territory of the respective contralateral nerve, mediated by
somatostatin release [40]. Such bilateral interaction has remained
QST in CRPS
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unexplained and even been ignored for a long time. In recent
publications, however, there is evidence from animal models as
well as from clinical studies, that both suspected pathomechan-
isms, neurogenic inflammation as well as small fibre degeneration,
show a bilateral distribution in unilateral animal models of chronic
joint pain (e.g. monoarthritis) or in neuropathic pain disorders, like
unilateral nerve injury and postherpetic neuralgia [41–43].
Conversely, evidence of small fibre degeneration in the innerva-
tion territory contralateral to the extremity affected by CRPS
could not be demonstrated [12]. Furthermore, consistent with our
results, Coderre and colleagues were able to detect a contralateral
spread of hyperalgesia in an animal model of acute CRPS [5].
These experimental findings are supported by clinical case reports,
which show contralateral sensory changes in other neuropathic
pain syndromes like trigeminal neuralgia [44]. Likely, contralateral
changes frequently remain undetected, because they are often
unincisive, and many studies lack an adequate control group.
Limitations of the Current Study
QST is a behavioural functional measure of sensory function.
Thus, it does not provide direct evidence of either structural loss of
axons innervating the tested area or phenotypic changes of sensory
nerve fibers.
So far, epidermal nerve fibre density and Quantitative Sensory
Testing show only weak correlations [45]. Although intra-
individual correlation is not warranted, however, sensory loss as
revealed by QST and axonal loss run in parallel as a group result
[46–48].
In the absence of structural changes, an increase in thermal
detection thresholds can also result from functional impairment of
a sensory pathway. Particularly, tactile but also thermal sensitivity
is modulated dynamically by nociceptive input, and hypoaesthesia
secondary to clinical as well as experimental pain conditions has
been delineated [49–51]. As tactile hypoaesthesia in those
experimental protocols seems to be related to the degree of
central (i.e. spinal or cortical) plasticity [52], the thermal
hypoaesthesia found in this study might be partially due to central
inhibition of non-noxious thermal input. However, the magnitude
of hypoaesthesia observed in our patients was more pronounced
than it would be expected from studies on pain induced
hypoaesthesia [50,52]. Therefore, it is unlikely that this type of
central plasticity can account for this degree of changes alone.
Furthermore, the involvement of supraspinal changes must be
taken into account, particularly in order to understand the
contralateral spread of symptoms. This is important, since
thalamic as well as cortical reorganisation has been demonstrated
to occur in patients suffering from CRPS I [14,53]. The sensory
changes observed in our patient cohort might well represent the
origin of cortical reorganisation in CRPS I, as central reorganisa-
tion can be mediated peripherally [54].
As a note of caution to the interpretation of our data, however,
the degree of cortical reorganisation in the respective studies
seemed to be associated with an impairment of tactile discrimi-
nation and was well correlated with the extent of mechanical
hyperalgesia [14,16,55]. Neither of these parameters nor a test for
mechanical allodynia was included in our test protocol. The latter
would also be capable to estimate the degree of central
sensitisation and hence maybe related to central reorganisation
[56]. Therefore, estimating the relative importance of central
changes may be more closely targeted by studies including a more
comprehensive protocol of sensory testing. Finally, a longitudinal
prospective follow-up study would enable to confirm the results of
this study and to identify possible ‘‘risk-profiles’’ for the
development of a chronic CRPS.
In conclusion, the present QST results suggest that in acute
CRPS I, aseptic neurogenic inflammation accompanies or even
initiates tissue changes, precipitating peripheral sensitisation and
thus leading to hyperalgesia. Concomitantly, the same fundamen-
tal process may also initiate a hitherto unknown sequence of
responses that eventually lead to the degeneration of small fibres.
The exact time course of these events is not delineated yet.
However, in chronic CRPS I, inflammation and ensuing signs of
peripheral hyperalgesia subside, while at the same time, the
degeneration of A-delta and C-fibres might further progress. It is
unknown, whether this represents a final stage of trophic changes.
All QST changes were, to a lesser degree, also present in the
contralateral limb, indicating that pathophysiological changes in
CRPS I might also be subclinically present in the extremity which
is not primarily affected by the disease.
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